BlockAide/CR
Alternative Names: BlockAide/CRLatest Information Update: 25 Jan 2007
At a glance
- Originator University of Texas M. D. Anderson Cancer Center
- Class
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 25 Jan 2007 Discontinued - Preclinical for HIV-1 infections in USA (Injection)
- 25 Jan 2007 Discontinued - Preclinical for HIV-1 infections in USA (PO)
- 17 Mar 2006 Preclinical trials in HIV-1 infections in USA (PO)